A pilot study on the use of serum glyoxalase as a supplemental biomarker to predict malignant cases of the prostate in the PSA range of 4-20 ng/ml

BACKGROUND & OBJECTIVES: Serum prostate specific antigen (PSA) though most commonly used for diagnosis of prostate cancer lacks specificity. This study was aimed at exploring the use of serum glyoxalase as a supplemental biomarker to differentiate between malignant vs non-malignant diseases of t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chavan, Sushant V., Chavan, Niraj R., Balaji, Anusha, Trivedi, Vatsala D., Chavan, Padma R.
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3237243/
https://ncbi.nlm.nih.gov/pubmed/22089607
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados